Establishment Labs Holdings Inc. (ESTA)
After hours:
| Previous close | 49.00 |
| Open | 48.15 |
| Bid | 49.61 x 100 |
| Ask | 50.20 x 200 |
| Day's range | 48.15 - 50.15 |
| 52-week range | 16.96 - 73.00 |
| Volume | |
| Avg. volume | 364,395 |
| Market cap | 1.373B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.07 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 60.33 |
Business WireEstablishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
NEW YORK, May 01, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that Jeff Ehrhardt has joined the company as General Manager of North America. After having spent over 25 years at Allergan Aesthetics, an Abbvie Company, Mr. Ehrhardt joins Establishment Labs with responsibilities including the anticipated launch of Motiva implants in
Business WireEstablishment Labs to Announce First Quarter 2024 Financial Results on May 8
NEW YORK, April 24, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.
Business WireEstablishment Labs Announces Participation in The Aesthetic Meeting 2024
NEW YORK, April 17, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2024, which is being held May 2-5 in Vancouver, BC Canada.
